Winfield Associates’s Adient ADNT Stock Holding History

Winfield Associates’s Portfolio ADNT Stock Details ADNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-5	Closed	-$1K	–	129
2017 Q4	$1K	Hold	5	–	–	﹤0.01%	728
2017 Q3	$0	Buy	+5	New	+$355	﹤0.01%	783

Other funds holding ADNT

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BHG

Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.94B AUM 9.49% 1-Year Est. Return

LAM

Lyrical Asset Management New York $7.88B AUM 36.5% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Winfield Associates's ADNT Position: Q1 2018 in Review

Winfield Associates sold out of Adient (ADNT) in Q1 2018, closing a stake of 5 shares — an estimated $1K sold.

Winfield Associates first reported a position in ADNT in Q3 2017 and held it in 2 quarters. The position peaked at $1K in Q4 2017. 402 funds tracked by Wall St. Rank hold ADNT as of Q1 2018.

Winfield Associates reported no remaining Adient position as of Q1 2018 after selling out during the quarter.
Winfield Associates sold 5 Adient shares in Q1 2018, an estimated $1K.
Winfield Associates first reported a position in Adient in Q3 2017 and held it in 2 quarters.
Winfield Associates's Adient position peaked at $1K in Q4 2017.
402 funds tracked by Wall St. Rank held Adient as of Q1 2018.

Based on Winfield Associates's 13F filing for Q1 2018, filed 10 May 2018.